Filter
1513
Text search:
stop
tb
Featured
157
427
Language
Document type
1091
144
135
64
29
17
16
6
5
3
3
Countries / Regions
80
50
48
44
38
35
32
32
32
32
32
29
27
27
26
25
19
19
18
18
16
16
15
14
14
14
12
12
11
9
9
7
7
6
5
5
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
630
127
58
57
37
17
16
Toolboxes
457
208
54
29
29
24
22
21
19
16
16
15
13
12
11
10
10
8
6
2
2
1
Key Populations Brief
Accessed November 2017
Rapport sur les populations clés.
28 September 2021
Less than half of required funding has been provided globally with dramatic consequences as
hundreds of thousands more die from TB
The purpose of this handbook is to bring together in summarized form the issues, recommended strategies and political measures involved in addressing each of the components of the STOP TB Strategy.
...
GDF is the largest global provider of quality-assured tuberculosis (TB)
medicines, diagnostics, and laboratory supplies to the public sector.
Since 2001, GDF has facilitated access to high-quality TB
...
Informe sobre poblaciones clave
Accessed November 2017
Rapport sur les populations clès
Accessed November 2017
This page contains documents and data related to the UN High-Level Meeting (HLM) on TB key targets and commitments for 2022 and outlined in the Political Declaration of the UN High-Level Meeting on the Fight Against
...
TEchnical Note
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
Blueprint for EECA countries, first edition
МОДЕЛЬ ПРОТИВОТУБЕРКУЛЕЗНОЙ ПОМОЩИ, ОРИЕНТИРОВАННАЯ НА НУЖДЫ ЛЮДЕЙ
Концептуальный проект модели для стран Восточной Европы и Центрально
...
Tuberculosis MDR-TB & XDR-TB The 2008 Report
Malawi Internationally recommended key policies uptake
How to make your messages on tuberculosis count
WHO/HTM/STB/2009.57
Accessed November 2017
Technical information note. Ensuring an uninterrupted supply of quality-assured, affordable anti-TB
drugs and diagnostics to the world
Fact sheet -Updated November 2015
Key population brief.
Краткое руководство.
Evidence from two pilot projects in India.
